Concepedia

Publication | Open Access

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors

DOIFull Paper Access

22

Citations

30

References

2021

Year

Akifumi Hagiwara, Talia C. Oughourlian, Nicholas S. Cho, Jacob Schlossman, Chencai Wang, Jingwen Yao, Catalina Raymond, Richard G. Everson, Kunal Patel, Sergey Mareninov,
Neuro-Oncology

Abstract

Elevated post-treatment rADC may be an early imaging biomarker for OS benefits in GBM patients receiving ICI treatment.

References

YearCitations

Page 1